業務
貨幣單位:美元
2024/Q1
名稱營收比例
Coronavirus disease 2019 (COVID-19)2,312.8萬42.73%
Human immunodeficiency virus (HIV)1,338萬24.72%
Molecular Sample Management Solutions1,082.2萬19.99%
Hepatitis C virus (HCV)300萬5.54%
Risk assessment testing208萬3.84%
Molecular Services87.3萬1.61%
Other product and service revenues49.6萬0.92%
Non-product and services revenues35.3萬0.65%
查看全部
地區
貨幣單位:美元
2023/FY
名稱營收比例
美國3.62億89.19%
其他地區3,570.1萬8.80%
歐洲811.1萬2.00%
